146 Results
Guidelines and Advice
Status: Archived
ID: 22-2-M
ID: 22-2-M
Jun 2014
Guidelines and Advice
Status: Current
ID: 4-13
Version: 3
ID: 4-13
Version: 3
Mar 2022
Guidelines and Advice
Status: Current
ID: 7-11
Version: 3
ID: 7-11
Version: 3
Mar 2022
Guidelines and Advice
Status: Current
ID: 7-16
Version: 4
ID: 7-16
Version: 4
Dec 2022
Guidelines and Advice
Status: Current
ID: GL 16-3
Version: 3
ID: GL 16-3
Version: 3
Mar 2022
Guidelines and Advice
Status: Current
ID: GL-C50-16
ID: GL-C50-16
Jun 2014
Guidelines and Advice
Status: Current
ID: 5-11
Version: 2
ID: 5-11
Version: 2
Jan 2022
Guidelines and Advice
Status: Current
ID: 11-6
Version: 2
ID: 11-6
Version: 2
Feb 2022
Guidelines and Advice
Status: Current
ID: GL 1-22-A
Version: 2
ID: GL 1-22-A
Version: 2
Jul 2022
Guidelines and Advice
Guidelines and Advice
Status: Current
ID: GL-C50-15
ID: GL-C50-15
Jun 2014
Drug
Other Name(s): Neulasta®
, Lapelga™
, Fulphila™
, Ziextenzo®
, Nyvepria™
Dec 2022